Investors Overview

Investors Overview

Our Mission

BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

Learn more about BD

News Releases

10/22/2020

Summary Toggle BD Announces Executive Leadership Appointments

Patrick Kaltenbach appointed chief technology officer Dave Hickey promoted to president, Life Sciences segment FRANKLIN LAKES, N.J. , Oct. 22, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced the appointment of

PDF Version
10/21/2020

Summary Toggle CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System

ZARAGOZA, Spain and FRANKLIN LAKES, N.J., Oct. 21, 2020 /PRNewswire/ -- CerTest Biotec, along with BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit adapted for the BD

PDF Version
10/07/2020

Summary Toggle BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship

Global Mercy will deliver free, world-class surgical care to patients in African nations who lack healthcare access FRANKLIN LAKES, N.J. , Oct. 7, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, this year celebrates its 25 year of

PDF Version
10/05/2020

Summary Toggle BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System

BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer FRANKLIN LAKES, N.J. , Oct. 5, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global

PDF Version
10/02/2020

Summary Toggle BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

FRANKLIN LAKES, N.J. , Oct. 2, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year 2020 earnings conference call on Thursday, November 5, 2020 , at 8:00 a.m. (ET) .

PDF Version
09/30/2020

Summary Toggle BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes

SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October FRANKLIN LAKES, N.J. , Sept. 30, 2020 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 antigen

PDF Version